Compare HUMA & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HUMA | NNOX |
|---|---|---|
| Founded | 2004 | 2011 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Electronics |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.6M | 155.6M |
| IPO Year | N/A | 2020 |
| Metric | HUMA | NNOX |
|---|---|---|
| Price | $1.01 | $2.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $10.00 | $7.00 |
| AVG Volume (30 Days) | ★ 6.1M | 1.4M |
| Earning Date | 03-27-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,571,000.00 | ★ $12,302,000.00 |
| Revenue This Year | N/A | $20.19 |
| Revenue Next Year | $731.05 | $137.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 15.19 |
| 52 Week Low | $0.88 | $2.11 |
| 52 Week High | $4.14 | $7.60 |
| Indicator | HUMA | NNOX |
|---|---|---|
| Relative Strength Index (RSI) | 46.36 | 33.13 |
| Support Level | $0.96 | $2.11 |
| Resistance Level | $1.03 | $2.50 |
| Average True Range (ATR) | 0.10 | 0.20 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 27.76 | 9.91 |
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.